Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance
Veterinary and Comparative Oncology · 2024
DOI: 10.1111/vco.12998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2024. Verfasst von Hun Kyeong Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, …. Hauptthemen laut MEDLINE: Dog Diseases, STAT3 Transcription Factor, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cooperative Research Program of Center for Companion Animal Research Rural Development Administration, Korea, Research Institute for Veterinary Science of Seoul National University.
Abstract (Originalsprache)
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3), which is related to anti‐apoptosis, cellular proliferation, invasion and migration of tumours, has prognostic significance in malignant tumours in humans as well as in canine melanoma. However, the significance of pSTAT3 in canine liver tissues has not yet been evaluated. This study's objective was to compare its expression in canine normal, non‐neoplastic hepatic disease and hepatocellular carcinoma (HCC) tissues by immunohistochemical analysis. Furthermore, the association between pSTAT3 immunostaining and clinicopathological factors was investigated. Overall, 68 canine liver tissues, including 10 normal liver tissues, 30 non‐neoplastic hepatic disease tissues and 28 HCC tissues were examined, revealing distinct differences in pSTAT3 immunostaining among the groups. ( p < 0.001). Additionally, high pSTAT3 immunostaining was significantly associated with increased tumour size (5 > cm) ( p = 0.041), and metastasis ( p = 0.046). Furthermore, Kaplan–Meier survival curve analysis revealed a correlation between high pSTAT3 immunostaining and poor disease‐free survival ( p = 0.013) and overall survival ( p = 0.011). These findings suggest that overactivation of STAT3 is associated with poor prognosis in canine HCC. Therefore, pSTAT3 is considered a potential prognostic marker and therapeutic target for canine HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
ORCID-Profile: Wan Hee Kim
Förderung
- Cooperative Research Program of Center for Companion Animal Research Rural Development Administration, Korea
- Research Institute for Veterinary Science of Seoul National University
Zitieren
APA
Shin, H. K., Chung, H. J., & Kim, W. H. (2024). Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12998
Vancouver
Shin HK, Chung HJ, Kim WH. Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance. Veterinary and Comparative Oncology. 2024. doi:10.1111/vco.12998
BibTeX
@article{Shin2024,
author = {Shin, Hun Kyeong and Chung, Hea Ji and Kim, Wan Hee},
title = {Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance},
journal = {Veterinary and Comparative Oncology},
year = {2024},
doi = {10.1111/vco.12998}
}
EUVIMED